ArticleBMC cancer2026

Differential predictive value of inflammation- and coagulation-based composite biomarkers for venous thromboembolism and mortality in patients with NSCLC receiving immune checkpoint inhibitors.

Jianying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.